TD Waterhouse Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.7K | Hold |
645
| – | – | ﹤0.01% | 1154 |
|
|
2025
Q1 | $43.6K | Hold |
645
| – | – | ﹤0.01% | 1115 |
|
|
2024
Q4 | $42.3K | Sell |
645
-8,315
| -93% | -$546K | ﹤0.01% | 1121 |
|
|
2024
Q3 | $630K | Sell |
8,960
-532
| -6% | -$37.4K | 0.01% | 573 |
|
|
2024
Q2 | $633K | Sell |
9,492
-703
| -7% | -$46.9K | 0.01% | 558 |
|
|
2024
Q1 | $817K | Buy |
10,195
+145
| +1% | +$11.6K | 0.01% | 536 |
|
|
2023
Q4 | $757K | Sell |
10,050
-678
| -6% | -$51.1K | 0.01% | 463 |
|
|
2023
Q3 | $766K | Sell |
10,728
-30
| -0.3% | -$2.14K | 0.01% | 445 |
|
|
2023
Q2 | $766K | Sell |
10,758
-23,385
| -68% | -$1.67M | 0.01% | 454 |
|
|
2023
Q1 | $2.16M | Buy |
34,143
+21,873
| +178% | +$1.38M | 0.02% | 309 |
|
|
2022
Q4 | $922K | Sell |
12,270
-189
| -2% | -$14.2K | 0.01% | 418 |
|
|
2022
Q3 | $860K | Sell |
12,459
-144
| -1% | -$9.94K | 0.01% | 426 |
|
|
2022
Q2 | $951K | Buy |
12,603
+96
| +0.8% | +$7.24K | 0.01% | 421 |
|
|
2022
Q1 | $938K | Sell |
12,507
-753
| -6% | -$56.5K | 0.01% | 466 |
|
|
2021
Q4 | $998K | Buy |
+13,260
| New | +$998K | 0.01% | 482 |
|